Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M, et al. JAMA 2023;330:1795-1797.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M, et al. Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA 2023;330:1795-1797.
PMID: 37796527